NSC |
Compound |
Enrichment |
Correlation |
NSC 684409 |
18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone |
0.029142074732756 |
0.21052059 |
NSC 686554 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- |
0.029142074732756 |
-0.20266906 |
NSC 693037 |
Null |
0.029142074732756 |
0.21288913 |
NSC 693248 |
Null |
0.029142074732756 |
0.16130615 |
NSC 693322 |
Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- |
0.029142074732756 |
0.065280671 |
NSC 710326 |
Null |
0.029142074732756 |
-0.0048774707 |
NSC 715407 |
Null |
0.029142074732756 |
0.40586653 |
NSC 718781 |
Erlotinib hydrochloride |
0.029142074732756 |
-0.44070338 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.029142074732756 |
0.23129085 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.029142074732756 |
0.16798774 |